drugset / Trial / NCT00654992

Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery

NCT00654992

Phase 2/3 Completed 71 enrolled Seoul National University Bundang Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to determine whether erythropoietin is effective in preventing acute kidney dysfunction after coronary artery bypass grafting surgery.

Timeline

Start
2006-09
Primary completion
2008-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Erythropoietin Beta Protein / enzyme biologic 300 iu/kg

Indications